Miso-Fem

For uterine evacuation

MISO-FEMtablets containing 200 mcg of Misoprostol: An effective, patient-centered, and safe option for uterine evacuation.

A synthetic prostaglandin analogue used in the management of obstetric and gynecological conditions
Prequalified by the World Health Organization *Only applicable to specific manufacturer
Available Presentation: Pack of 4 tablets and Pack of 12 tablets.
For first-trimester medical abortion: effective both alone (87%)¹ and in combination with mifepristone (96%)²
Mechanism of action: Misoprostol acts to soften the cervix and contract the uterus to expel uterine contents
Contraindications to medical abortion drugs include suspected ectopic pregnancy, bleeding disorders, allergies, or the presence of an IUD

1 Raymond, Elizabeth G. MD, MPH; Harrison, Margo S. MD, MPH; Weaver, Mark A. PhD. Efficacy of Misoprostol Alone for First-Trimester Medical Abortion: A Systematic Review. Obstetrics & Gynecology 133(1):p 137-147, January 2019.
2 Chen, Melissa J. MD, MPH; Creinin, Mitchell D. MD. Mifepristone With Buccal Misoprostol for Medical Abortion: A Systematic Review. Obstetrics & Gynecology 126(1):p 12-21, July 2015.

Benefits:

Easy to use: The dosage for this method is simple and straightforward, making it user-friendly and easy to administer.
Convenience: It can be taken privately at home, providing a convenient option for individuals seeking privacy and comfort during the process.
Non-invasive: This method does not require anesthesia or surgery, eliminating the need for invasive procedures and their associated risks.

Uses:

Miscarriage management: effective and highly acceptable for treating miscarriage or incomplete abortion.
Cervical ripening: effective ripening agent prior to first-trimester aspiration abortion, used prior to endometrial biopsy or IUD insertion.
Labor induction: highly effective for inducing vaginal delivery at a dose of 25 mcg.
Postpartum hemorrhage (PPH): used for prevention and treatment of PPH.